Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
VISEN Pharmaceuticals logo — Achieve better treatment processes and outcomes by combining...

VISEN Pharmaceuticals

Achieve better treatment processes and outcomes by combining global expertise and strength in endocrine therapies

Founded 2018 China China 42 employees Series B Total: $190.00M Biotechnology, Life Sciences +1

General Information

Company Name VISEN Pharmaceuticals
Founded Year 2018
Location China China +1
Founders / Decision Makers
Team member
Employees 42
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Series B
Social

Get notified when VISEN Pharmaceuticals moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About VISEN Pharmaceuticals

Visen Pharmaceuticals is an innovative biopharmaceutical company dedicated to providing innovative therapies and compassionate, patient-centric care for endocrine diseases. Their focus on endocrine diseases in adults and children, and rare endocrine diseases reflects their commitment to addressing diverse patient needs. The company's global expertise and strength in endocrine therapies is exemplified by their team of seasoned professionals with multinational pharmaceutical experiences and their leveraging of cutting-edge technologies and leading resources across the world. Establishing themselves firmly in the Chinese market, with offices in Shanghai, Beijing, Hong Kong, and Taipei, and a state-of-the-art R&D and manufacturing site in Suzhou, reflects their commitment to enhancing R&D, manufacturing, and commercialization efforts. This positioning aims to enable Chinese endocrine patients to benefit from advanced treatment solutions earlier, reflecting a patient-centric approach. In 2018, Visen Pharmaceuticals was formed by Ascendis Pharma A/S (Nasdaq: ASND) and an investor syndicate led by Vivo Capital (with participation by Sofinnova Ventures), to develop and commercialize Ascendis Pharma's endocrinology therapies in Greater China, including mainland China, Hong Kong, Macau, and Taiwan. Their recent $150 million Series B financing led by Sequoia China in January 2021 with participation from OrbiMed, Sherpa Healthcare Partners, Cormorant, HBM Healthcare Investments, Pivotal bioVenture Partners China, Logos Capital, and CDG Capital, alongside existing investors, including Ascendis Pharma A/S, Vivo Capital, and Sofinnova Investments, signifies a strong vote of confidence from the investor community. This substantial investment underlines the potential and progress of Visen Pharmaceuticals in advancing endocrine therapies and expanding their impact in Greater China.

Taxonomy: biopharmaceutical, endocrine therapies, patient-centric care, R&D, pharmaceutical, investment, Series B financing, innovation, treatment processes, multinational, China market, Ascendis Pharma A/S, VIVO Capital

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 10
Investor Investor Investor Investor Investor Investor Investor
•••• •••• 		08 Jan 2021
Series A •••••• - 13 Nov 2018

FAQ About VISEN Pharmaceuticals

Achieve better treatment processes and outcomes by combining global expertise and strength in endocrine therapies
VISEN Pharmaceuticals was founded in 2018.
VISEN Pharmaceuticals is headquartered in China.
VISEN Pharmaceuticals operates in the following industries: Biotechnology, Life Sciences, Pharmaceutical.
VISEN Pharmaceuticals has approximately 42 employees.
VISEN Pharmaceuticals has completed 2 funding rounds, raising a total of $190.00M. The latest funding stage is Series B.

We're actively collecting intelligence on VISEN Pharmaceuticals.

Track VISEN Pharmaceuticals to get notified

Don't just browse. Track.

Signal Tracker monitors VISEN Pharmaceuticals and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy